Sevion Therapeutics Report issue

For profit Phase 2
Founded: Princeton NJ United States (1964)
Status: Acquired by Eloxx Pharmaceuticals, Inc. (2017)

Organization Overview

First Clinical Trial
2011
NCT01435720
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree